<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03225950</url>
  </required_header>
  <id_info>
    <org_study_id>H-16024734</org_study_id>
    <nct_id>NCT03225950</nct_id>
  </id_info>
  <brief_title>Interaction Between Immune Cells and Bacteria Associated With Periodontitis</brief_title>
  <official_title>Interaction Between Immune Cells and Bacteria Associated With Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Copenhagen University Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Association of Dental Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Dental Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the interaction between host immune cells and bacteria associated with
      periodontitis. It comprises biological material from donors with and without periodontal
      disease. Specifically, we collect a spit and blood sample to conduct in vitro stimulations
      and measurements of selected parameters related to periodontitis to clarify obscure areas in
      the immunologic pathogenesis of this disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodontitis is a prevalent, multifactorial inflammatory disease characterized by the
      interaction between microorganisms organized in biofilms on tooth surfaces and host immune
      cells, leading to an inflammatory destruction of the tooth-supporting tissues and - if left
      untreated - eventually tooth loss. Periodontitis affects up to 50% of the population in the
      United States of America, and is classified in an aggressive and a chronic form depending on
      genetic factors, age of onset, speed and severity of attachment loss.

      The onset of periodontitis is caused by an immunologic imbalance between host immune cells
      and residing microorganisms in subgingival pockets. The host immune cells are capable of
      enhancing both a protective and a destructive inflammatory response towards the
      microorganisms through the release of inflammatory mediators e.i. proinflammatory and
      antiinflammatory cytokines.

      The role of antibodies in periodontitis is also unclear. Some studies show an excessive
      antibody level against bacteria associated with periodontitis e.g. Porphyromonas gingivalis
      (P.g.).

      In general, this study contributes to a profound understanding of the host immune cells role
      in the onset and pathogenesis of periodontitis by comparing healthy versus diseased donors
      immunologic responses toward pathogene and apathogene microorganisms and their genetic
      background.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">August 29, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 29, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>periodontitis-associated- and control bacterial stimulation of host immune cells.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Identification and determination of the amount of cytokine-producing immune cells when stimulated with bacteria associated with periodontitis including pro- and antiinflammatory cytokines.
Genuses: Porphyromonas, Prevotella, Eikenella, Aggregatibacter, Actinomyces, Lactobacillus, Bifidobacterium, Rothia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anti-cyclic citrullinated peptides (anti-CCP) antibodies titers.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Determination of the prevalence of anti-CCP-positive periodontitis patients through measure of anti-CCP antibody titers in serum samples and correlation with the level of antibodies to P. gingivalis, and to the abundancy of the bacterium in saliva.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>P. gingivalis presence and related antibodies.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Determination of P. gingivalis presence in saliva and serum samples through RT-qPCR and determination of the level of antibodies towards the bacterium using in-house Luminex-based technology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Single nucleotide polymorphism (SNP) analysis.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Investigation of the potential association between periodontitis and selected polymorphisms in the PADI genes using multiplex bead-based SNP assays with the Luminex technology.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cytokine profile in saliva.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Determination of the cytokine profile in saliva samples from subject with periodontitis and healthy controls with Luminex based technology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of other periodontal bacteria.</measure>
    <time_frame>Aug. 2020</time_frame>
    <description>Determination of the presence of other periodontal bacteria through RT-qPCR assays.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Periodontal Diseases</condition>
  <condition>Periodontitis</condition>
  <condition>Aggressive Periodontitis</condition>
  <condition>Immunologic Disease</condition>
  <condition>Microbial Disease</condition>
  <condition>Periodontal Pocket</condition>
  <condition>Inflammation</condition>
  <condition>Inflammation Gum</condition>
  <condition>Dysbiosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Generalized Aggressive Periodontitis</condition>
  <condition>Generalized Chronic Periodontitis</condition>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Chronic periodontitis donors</arm_group_label>
    <description>Donors are medically healthy.
Slow to moderate attachment loss and bone destruction.
Good correlation between etiological factors and serverity of attachment loss.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aggressive periodontitis donors</arm_group_label>
    <description>Donors are medically healthy.
Rapid attachment loss and bone destruction.
Familial aggregation.
No correlation between etiological factors and serverity of attachment loss.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control donors</arm_group_label>
    <description>Donors are medically healthy.
No sign of inflammatory conditions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In vitro stimulation of blood with periodontitis-associated- and control bacteria</intervention_name>
    <description>Peripheral mononuclear blood cells are stimulated with periodontitis-associated- and control bacteria to measure the amount of positive cytokine-producing cells.</description>
    <arm_group_label>Chronic periodontitis donors</arm_group_label>
    <arm_group_label>Aggressive periodontitis donors</arm_group_label>
    <arm_group_label>Control donors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Anti-CCP- and anti-P.g.-antibodies titers</intervention_name>
    <description>Anitbody titers will be measured in saliva and serum samples.</description>
    <arm_group_label>Chronic periodontitis donors</arm_group_label>
    <arm_group_label>Aggressive periodontitis donors</arm_group_label>
    <arm_group_label>Control donors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Analysis of selected single nucleotide polymorphisms (SNPs)</intervention_name>
    <description>DNA obtained from saliva samples will be used to determine the genotype of the participants for selected SNPs.</description>
    <arm_group_label>Chronic periodontitis donors</arm_group_label>
    <arm_group_label>Aggressive periodontitis donors</arm_group_label>
    <arm_group_label>Control donors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>periodontitis-associated bacteria presence</intervention_name>
    <description>Determination of the presence of periodontitis-associated bacteria e.i. Porphyromonas gingivalis in saliva and blood samples.</description>
    <arm_group_label>Chronic periodontitis donors</arm_group_label>
    <arm_group_label>Aggressive periodontitis donors</arm_group_label>
    <arm_group_label>Control donors</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva, whole blood, peripheral mononuclear blood cells, serum, plasma.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study includes 170 participants, which are legally competent e.i. above 18 years of
        age and general decision competent. The participants are divided into three groups: 1)
        Participants with chronic periodontitis (n=35), 2) participants with aggressive
        periodontitis (n=35) and 3) healthy participants without periodontal disease (n=100). The
        participants are recruited from the Department of Odontology, Faculty of Health and Medical
        Sciences, University of Copenhagen, Copenhagen, Denmark and assigned to a group in
        accordance with the periodontal disease classification system in 1999 American Academy of
        Periodontology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for chronic periodontitis donors:

          -  50-60 years of age.

          -  Interproximal attachment loss at minimum 3 teeth besides molars and incisors.

          -  Clinical attachment loss at minimum 10 sites identified by bleeding and pus upon
             probing.

          -  Visible radiographic bone loss.

          -  Medically healthy donors.

        Inclusion criteria for aggressive periodontitis donors:

          -  19-40 years of age.

          -  Interproximal attachment loss at minimum 3 teeth besides molars and incisors.

          -  Clinical attachment loss at minimum 10 sites identified by bleeding and pus upon
             probing.

          -  Visible radiographic bone loss.

          -  Medically healthy donors.

        Inclusion criteria for healthy donors: (age: 19-40 years; 50-60 years)

          -  No sign of inflammatory conditions or other general systemic diseases.

          -  Medically healthy donors.

        Exclusion criteria for all groups:

          -  Pregnant and breastfeeding.

          -  Antibiotic treatment within 6 months.

          -  Suffer from periodontal manifestations caused by systemic diseases e.i. genetic
             diseases, haematologic anomalies or syndromes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Palle Holmstrup, DDS, PhD, Dr Odont</last_name>
    <role>Study Director</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claus Henrik Nielsen, PhD, MSc, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Katrine Danielsen, No Degree</last_name>
    <phone>004522670101</phone>
    <email>rbs334@alumni.ku.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian Damgaard, DDS, PhD</last_name>
    <phone>004525323832</phone>
    <email>chrd@sund.ku.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital.</name>
      <address>
        <city>Copenhagen</city>
        <zip>2200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Katrine Danielsen, No degree</last_name>
      <phone>004522670101</phone>
      <email>rbs334@alumni.ku.dk</email>
    </contact>
    <contact_backup>
      <last_name>Christian Damgaard, DDS, PhD</last_name>
      <phone>004525323832</phone>
      <email>chrd@sund.ku.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Palle Holmstrup, DDS, PhD, Dr Odont</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013 Jun;62(1):203-17. doi: 10.1111/j.1600-0757.2012.00450.x. Review.</citation>
    <PMID>23574467</PMID>
  </reference>
  <reference>
    <citation>Neely AL, Holford TR, Löe H, Anerud A, Boysen H. The natural history of periodontal disease in man. Risk factors for progression of attachment loss in individuals receiving no oral health care. J Periodontol. 2001 Aug;72(8):1006-15.</citation>
    <PMID>11525431</PMID>
  </reference>
  <reference>
    <citation>Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015 May;86(5):611-22. doi: 10.1902/jop.2015.140520. Epub 2015 Feb 17.</citation>
    <PMID>25688694</PMID>
  </reference>
  <reference>
    <citation>Armitage GC. Development of a classification system for periodontal diseases and conditions. Northwest Dent. 2000 Nov-Dec;79(6):31-5.</citation>
    <PMID>11413609</PMID>
  </reference>
  <reference>
    <citation>Haffajee AD, Socransky SS, Patel MR, Song X. Microbial complexes in supragingival plaque. Oral Microbiol Immunol. 2008 Jun;23(3):196-205. doi: 10.1111/j.1399-302X.2007.00411.x.</citation>
    <PMID>18402605</PMID>
  </reference>
  <reference>
    <citation>Damgaard C, Holmstrup P, Van Dyke TE, Nielsen CH. The complement system and its role in the pathogenesis of periodontitis: current concepts. J Periodontal Res. 2015 Jun;50(3):283-93. doi: 10.1111/jre.12209. Epub 2014 Jul 5. Review.</citation>
    <PMID>25040158</PMID>
  </reference>
  <reference>
    <citation>Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000. 2010 Feb;52(1):163-206. doi: 10.1111/j.1600-0757.2009.00321.x. Review.</citation>
    <PMID>20017801</PMID>
  </reference>
  <reference>
    <citation>Kinane DF, Preshaw PM, Loos BG; Working Group 2 of Seventh European Workshop on Periodontology. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011 Mar;38 Suppl 11:44-8. doi: 10.1111/j.1600-051X.2010.01682.x.</citation>
    <PMID>21323703</PMID>
  </reference>
  <reference>
    <citation>Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1250-4. Epub 2003 Apr 24.</citation>
    <PMID>12714435</PMID>
  </reference>
  <reference>
    <citation>Pussinen PJ, Nyyssönen K, Alfthan G, Salonen R, Laukkanen JA, Salonen JT. Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):833-8. Epub 2005 Feb 3.</citation>
    <PMID>15692101</PMID>
  </reference>
  <reference>
    <citation>Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol. 2005;32 Suppl 6:87-107. Review.</citation>
    <PMID>16128832</PMID>
  </reference>
  <reference>
    <citation>Fillatreau S. Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii80-4. doi: 10.1136/annrheumdis-2012-202253. Epub 2012 Dec 19. Review.</citation>
    <PMID>23253921</PMID>
  </reference>
  <reference>
    <citation>Belstrøm D, Paster BJ, Fiehn NE, Bardow A, Holmstrup P. Salivary bacterial fingerprints of established oral disease revealed by the Human Oral Microbe Identification using Next Generation Sequencing (HOMINGS) technique. J Oral Microbiol. 2016 Jan 14;8:30170. doi: 10.3402/jom.v8.30170. eCollection 2016.</citation>
    <PMID>26782357</PMID>
  </reference>
  <reference>
    <citation>Belstrøm D, Holmstrup P, Bardow A, Kokaras A, Fiehn NE, Paster BJ. Comparative analysis of bacterial profiles in unstimulated and stimulated saliva samples. J Oral Microbiol. 2016 Mar 16;8:30112. doi: 10.3402/jom.v8.30112. eCollection 2016.</citation>
    <PMID>26987356</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2017</study_first_submitted>
  <study_first_submitted_qc>July 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>July 22, 2017</last_update_submitted>
  <last_update_submitted_qc>July 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Anne Katrine Danielsen</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Periodontal disease</keyword>
  <keyword>Periodontitis</keyword>
  <keyword>Aggressive periodontitis</keyword>
  <keyword>Dysbiosis</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Regulation</keyword>
  <keyword>Cytokines</keyword>
  <keyword>Bacteria</keyword>
  <keyword>Porphyromonas gingivalis</keyword>
  <keyword>Saliva</keyword>
  <keyword>Anti-CCP</keyword>
  <keyword>Peptidyl arginine deiminases</keyword>
  <keyword>Single nucleotide polymorphisms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Aggression</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
    <mesh_term>Aggressive Periodontitis</mesh_term>
    <mesh_term>Dysbiosis</mesh_term>
    <mesh_term>Periodontal Pocket</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be available to other researchers in accordance with our approved Human Subjects Protection application in Denmark.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

